Galenea's Grant - IV Round

Galenea raised a round of funding on September 23, 2011. Investors include National Institute of Mental Health.

Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, A…

Articles about Galenea's Grant - IV Round: